Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03779932
Other study ID # BCA-20
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 23, 2015
Est. completion date February 24, 2016

Study information

Verified date December 2018
Source Seca GmbH & Co. Kg.
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The study was based on the clinical trial BCA-01 (NCT01368640) "Generation of prediction equations to analyze body composition of adults based on Bioelectrical Impedance Analysis (BIA)" and implicates an extension of the study collective. Aim of the study is to develop prediction equations for calculating FFM, TBW, ECW and SMM based on the gold standard reference methods ADP, DXA, MRI, D2O and NaBr on the one hand and measurement data of the BIA devices on the other hand.


Recruitment information / eligibility

Status Completed
Enrollment 38
Est. completion date February 24, 2016
Est. primary completion date February 24, 2016
Accepts healthy volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- healthy adults in an

- age range of 18 to 65 years

- BMI > 30 kg/m2

Exclusion Criteria:

- acute and chronic diseases

- regular intake of medications (except for contraceptives)

- amputation of limbs

- electrical implant as cardiac pacemaker

- insulin pumps

- artificial joints

- metallic implants (except tooth implants)

- claustrophobia

- pregnancy or breastfeeding period

- probands who cannot provide an ICF by themselves

- probands who might be dependent from the sponsor or the inv. site

- current alcohol abuse

- frequent hypersensitivity reactions/allergies determ. anamnestically

- extensive tattoos at arms or legs

Study Design


Related Conditions & MeSH terms

  • Bioelectrical Impedance Measurement of Healthy Adults

Locations

Country Name City State
Germany Institute of Human Nutrition and Food Science Kiel

Sponsors (1)

Lead Sponsor Collaborator
Seca GmbH & Co. Kg.

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary BIA 5 and 50 kHz Bioelectrical Impedance of 5 and 50 kHz for one body side 15 minutes
Primary BIA 50 kHz Bioelectrical Impedance of 50 kHz for all 4 extremities 15 minutes
Primary Total body water Total body water (TBW) by deuterium (D2O) dilution 15 minutes
Primary Extracellular water Extracellular water (ECW) by NaBr dilution 15 minutes
Primary Fat-free mass Fat-free mass by a 4-compartment model based on dual energy x-ray absorption (DXA), air displacement plethysmography (ADP), D2O dilution and weight 1 hour
Primary Skeletal muscle mass Skeletal muscle mass (SMM) by magnetic resonance imaging (MRI) 1 hour
Primary Visceral adipose tissue Visceral adipose tissue VAT by magnetic resonance imaging (MRI) 1 hour
Secondary Complete BIA Bioelectrical Impedance of 1, 1.5, 2, 3, 7.5, 10, 15, 20, 30, 75, 100, 150, 200, 300, 500, 750 and 1,000 kHz for all body segments: right arm, left arm, right leg, left leg, trunk, right body side and left body side. 15 minutes
See also
  Status Clinical Trial Phase
Completed NCT04030416 - Comparing Medical Body Composition Analyzer Seca mBCA 555 With Seca mBCA 515
Completed NCT01471938 - Application and Adaption of Device Specific Body Composition Formulas to Various Ethnic Groups N/A
Completed NCT01368640 - Generation of Prediction Equations to Analyze Body Composition of Adults Based on Bioelectrical Impedance Analysis (BIA) N/A